These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30783647)

  • 41. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?
    Nafasi L; Rahmani R; Shafiee A; Salari A; Abdollahi A; Meysamie A
    Curr Med Res Opin; 2014 Mar; 30(3):381-6. PubMed ID: 23952289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of mTOR inhibitors and HMG-CoA reductase inhibitors on young and old endothelial cell functions, critical for re-endothelialisation after percutaneous coronary intervention: an in vitro study.
    Korybalska K; Kawka E; Breborowicz A; Witowski J
    J Physiol Pharmacol; 2017 Jun; 68(3):397-405. PubMed ID: 28820396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes.
    Tentzeris I; Rohla M; Jarai R; Farhan S; Freynhofer MK; Unger G; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K
    Am J Cardiol; 2014 Apr; 113(7):1099-104. PubMed ID: 24462073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis.
    Lotfi A; Schweiger MJ; Giugliano GR; Murphy SA; Cannon CP;
    Am Heart J; 2008 May; 155(5):954-8. PubMed ID: 18440347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes.
    Berent R; Berent T; Karkutli E; Sinzinger H
    Am J Cardiol; 2014 Oct; 114(7):1128-9. PubMed ID: 25212554
    [No Abstract]   [Full Text] [Related]  

  • 47. Statins for the prevention of contrast-induced acute kidney injury.
    Ball T; McCullough PA
    Nephron Clin Pract; 2014; 127(1-4):165-71. PubMed ID: 25343843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ample evidence for statins preloading before PCI on periprocedural myocardial infarction among stable angina pectoris patients undergoing percutaneous coronary intervention.
    Shariff M; Kumar U A
    Cardiovasc Revasc Med; 2019 Jun; 20(6):533-534. PubMed ID: 31000432
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of high-dose atorvastatin pretreatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a cardiac magnetic resonance study.
    Kim EK; Hahn JY; Song YB; Chang SA; Choi JH; Choi SH; Lee SC; Choe YH; Lee SH; Gwon HC
    J Korean Med Sci; 2015 Apr; 30(4):435-41. PubMed ID: 25829811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The impact of different doses of atorvastatin on plasma endothelin and platelet function in acute ST-segment elevation myocardial infarction after emergency percutaneous coronary intervention].
    Xu XR; Li KB; Wang P; Xu L; Liu Y; Yang ZS; Yang XC
    Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):932-936. PubMed ID: 27916047
    [No Abstract]   [Full Text] [Related]  

  • 51. [JAPAN-ACS (Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome)].
    Dohi T; Daida H
    Nihon Rinsho; 2016 Jun; 74 Suppl 4 Pt 1():697-702. PubMed ID: 27534254
    [No Abstract]   [Full Text] [Related]  

  • 52. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes.
    Marenzi G; Cosentino N; Werba JP; Tedesco CC; Veglia F; Bartorelli AL
    Int J Cardiol; 2015 Mar; 183():47-53. PubMed ID: 25662053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention.
    Mood GR; Bavry AA; Roukoz H; Bhatt DL
    Am J Cardiol; 2007 Sep; 100(6):919-23. PubMed ID: 17826370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of statins preloading before PCI on periprocedural myocardial infarction among stable angina pectoris patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Soud M; Ho G; Kuku KO; Hideo-Kajita A; Waksman R; Garcia-Garcia HM
    Cardiovasc Revasc Med; 2018 Dec; 19(8):971-975. PubMed ID: 30056022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statins and contrast-induced acute kidney injury with coronary angiography.
    Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
    Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy.
    Patti G; Chello M; Gatto L; Alfano G; Miglionico M; Covino E; Di Sciascio G
    J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):795-800. PubMed ID: 20613550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial.
    Abbasi SH; Mohammadinejad P; Shahmansouri N; Salehiomran A; Beglar AA; Zeinoddini A; Forghani S; Akhondzadeh S
    J Affect Disord; 2015 Sep; 183():149-55. PubMed ID: 26005776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study.
    Leoncini M; Toso A; Maioli M; Angiolillo DJ; Giusti B; Marcucci R; Abbate R; Bellandi F
    JACC Cardiovasc Interv; 2013 Feb; 6(2):169-79. PubMed ID: 23428009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Routine statin treatment after acute coronary syndromes?
    Acevedo M; Sprecher DL; Lauer MS; Francis G
    Am Heart J; 2002 Jun; 143(6):940-2. PubMed ID: 12075242
    [No Abstract]   [Full Text] [Related]  

  • 60. Relationship between statin type and responsiveness to clopidogrel in patients treated with percutaneous coronary intervention: a subgroup analysis of the CILON-T trial.
    Suh JW; Cha MJ; Lee SP; Chae IH; Bae JH; Kwon TG; Bae JW; Cho MC; Rha SW; Kim HS
    J Atheroscler Thromb; 2014; 21(2):140-50. PubMed ID: 24140730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.